News

Plus Therapeutics shares are trading higher by 244% during Thursday's session. The company announced that the FDA accepted the name REYOBIQ for the company's lead asset. The ‘Trade of the Day ...
HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced ...
March 19, 2025 (GLOBE NEWSWIRE) -- Servier, an independent global pharmaceutical group governed by a non-profit foundation, and Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage ...
The company will henceforth be known as Whitehawk Therapeutics, it announced Tuesday. Its stock ticker will be updated accordingly: As of Wednesday, it will trade as “WHWK” on the Nasdaq ...
On Tuesday, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock is sliding. The company shared an update on Elevidys (delandistrogene moxeparvovec-rokl), the only approved gene therapy in patients with ...
On Tuesday, Indaptus Therapeutics, Inc. (NASDAQ:INDP) announced it advanced to a new expansion arm of its Phase 1b/2 clinical trial of Decoy20. The expansion will evaluate the combination of ...
Peptris Technologies, an AI-powered drug discovery company, announced that it has entered into a licensing agreement with Revio Therapeutics, a specialty pharma start-up focused on repurposing and ...
In a world where speed and convenience are paramount to customers, logistic providers are turning to emerging technologies such as artificial intelligence and robotics to stay competitive.
"We are not spending nearly enough time focusing on the bottom of the pyramid," Bryant told CNBC's Julia Boorstin at CONVERGE LIVE in Singapore on Wednesday. "Convenience store [jobs are] gone ...